Nakm tab. 250mg/25mg №10

Use Nakom is used for the treatment of Parkinson's disease and parkinsonian syndrome (with the exception of that caused by antipsychotic drugs), including post-encephalitic, against the background of cerebrovascular diseases, as well as intoxication with toxic substances (including carbon monoxide or manganese). How to take The optimal daily dose of Nakom should be determined by careful selection for each patient. The tablets contain carbidopa and levodopa in a 1:10 ratio. To achieve an optimal level of peripheral dopa-decarboxylase inhibition, at least 70-100 mg of carbidopa should be administered daily. Clinical experience with carbidopa in a daily dose exceeding 200 mg is limited. The maximum recommended dose is eight Nakom tablets per day (2 g levodopa and 200 mg carbidopa). This is approximately 3 mg of carbidopa and 30 mg of levodopa per kilogram of body weight for a patient weighing 70 kg. Contraindications - Hypersensitivity to any component of the drug. - Concomitant use with non-selective MAO inhibitors (these drugs should be discontinued at least two weeks before starting Nakom treatment). - Angle-closure glaucoma. - Melanoma or suspected melanoma. - Skin diseases of unknown etiology. - Pregnancy and breastfeeding period. - Children's age. Storage Store at a temperature not exceeding 25 degreeC in a dry, dark place. Keep out of reach of children.